Colombian experience in the treatment of hepatitis c with direct-acting antiviral agents

There are few published real-world studies on hepatitis C in Latin America. This paper describes a cohort of Colombian subjects treated with direct-acting antiviral agents. A total of 195 patients from 5 hepatology centers in 4 Colombian cities were retrospectively studied. For each patient, serum b...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2019
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
spa
OAI Identifier:
oai:repository.urosario.edu.co:10336/22572
Acceso en línea:
https://repository.urosario.edu.co/handle/10336/22572
Palabra clave:
Alanine aminotransferase
Antivirus agent
Aspartate aminotransferase
Asunaprevir
Biological marker
Daclatasvir
Daclatasvir plus ribavirin
Daclatasvir plus simeprevir
Dasabuvir
Ledipasvir
Ledipasvir plus ribavirin
Ledipasvir plus sofosbuvir
Ombitasvir
Paritaprevir
Paritaprevir plus ribavirin
Ribavirin
Ribavirin plus sofosbuvir
Ritonavir
Simeprevir
Sofosbuvir
Unclassified drug
Antivirus agent
Virus rna
Adult
Aged
Alanine aminotransferase blood level
Anemia
Anxiety disorder
Article
Aspartate aminotransferase blood level
Asthenia
Brain disease
Cholelithiasis
Cohort analysis
Colombia
Diarrhea
Drug efficacy
Fatigue
Female
Genotype
Headache
Hepatitis c
Human
Intermethod comparison
Liver cirrhosis
Liver toxicity
Liver transplantation
Major clinical study
Male
Multicenter study
Nausea
Nonhuman
Pruritus
Rash
Retrospective study
Sustained virologic response
Treatment outcome
Virus load
Vomiting
Clinical trial
Combination drug therapy
Genetics
Hepacivirus
Hepatitis c
Middle aged
Nonparametric test
Aged
Antiviral agents
Colombia
Female
Genotype
Hepacivirus
Hepatitis c
Humans
Liver transplantation
Male
Middle aged
Retrospective studies
Sustained virologic response
Viral load
Antiviral agents
Chronic hepatitis
Drug therapy
Hepatitis c
Liver transplantation
Treatment outcome
viral
combination
nonparametric
Drug therapy
Rna
Statistics
Rights
License
Abierto (Texto Completo)